Urodynamic effect of one single vaginal application of 2 mL of V0162 gel (0.8%) in post-menopausal women with overactive bladder
Urodynamic effect of one single vaginal application of 2 mL of V0162 gel (0.8%) in post-menopausal women with overactive bladder
Urodynamic effect of one single vaginal application of 2 mL of V0162 gel (0.8%) in post-menopausal women with overactive bladder
Status
Status :
Completed
Type of study
Phase II
Min. Age
18
Years old
Max. Age
-
Gender
Female
Therapeutic area :
Urology
Disease :
Oevracive bladder
Study medication :
V0162
Phase :
Phase II
Start Date :
11 July 2011
End date :
13 October 2011
Study ID :
V00162 GL 203
EudraCT/CTIS number :
2010-024271-10
Send by email